Deploying POKE Within Intermountain Healthcare

NCT03688607 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2600

Last updated 2018-09-28

No results posted yet for this study

Summary

To assess the impact of POKE on babies, the investigators will longitudinally track outcomes before and after implementation at Intermountain Healthcare's five NICUs. Process outcomes will include the number of total POKEs per baby and the number of painful POKEs per baby, each measured at both the patient-level and NICU-level. Clinical outcomes will include hospital acquired infections, length of stay, and mortality. Financial outcomes will include total variable costs and backfill rate. The effect of POKE on each of these outcomes will be measured using multivariable regression analysis with appropriate distributional families and interaction terms.

Conditions

  • Newborn; Infection

Interventions

PROCEDURE

There will not be an intervention, rather the investigators will deploy best practices and track POKEs within the healthcare system to evaluate clinical and operational outcomes.

There will not be an intervention, rather the investigators will deploy best practices and track POKEs within the healthcare system to evaluate clinical and operational outcomes.

Sponsors & Collaborators

  • Intermountain Health Care, Inc.

    lead OTHER

Principal Investigators

  • R. Erick Ridout, MD · Intermountain Health Care, Inc.

  • Terri Kane, RN, MBA · Intermountain Health Care, Inc.

  • Brad Isaacson, PhD, MBA, MSF · Intermountain Health Care, Inc.

Eligibility

Max Age
12 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2019-04-30
Completion
2019-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03688607 on ClinicalTrials.gov